The effect of exercise training with ingested of vitamin D on angiogenesis

Investigate and Compare the Effect of Eight Weeks Resistance and Endurance Training with Vitamin D Supplementation on Some Serum Angiogenesis Indices in Obese Hypertensive Meedle- Aged Men

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017062421719N1

Enrollment

Registered

2017-08-16

Start date

2016-04-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: The subjects of resistance exercise with vitamin- D group participated in 8 weeks of resistance training with ingested of vitamin- D supplement. Blood sample were taken in basal state

Prevention

The subjects of resistance exercise with vitamin- D group participated in 8 weeks of resistance training with ingested of vitamin- D supplement. Blood sample were taken in basal state and after 8 week

The subjects of endurance exercise with vitamin- D group participated in 8 weeks of endurance training with ingested of vitamin- D supplement. Blood sample were taken in basal state and after 8 week

The subjects of endurance exercise with placebo group participated in 8 weeks of endurance training with ingested of placebo. Blood sample were taken in basal state and after 8 week.

The subjects of resistance exercise with placebo group participated in 8 weeks of resistance training with ingested of placebo. Blood sample were taken in basal state and after 8 week.

The subjects of vitamin- D group participated in 8 weeks of ingested of vitamin- D supplement. Blood sample were taken in basal state and after 8 week.

The subjects of control group (There was no intervention). Blood sample were taken in basal state and after 8 week.

Eligibility

Sex/Gender

Male

Age

35 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: non-athletic, Being in the age range of 35 to 45 years old, Being male, obesity and having high blood pressure (subjects were on the threshold of having hypertension, but not taking the drug that reduce blood pressure). Exclusion criteria: Taking the drug that reduce blood pressure and smoking,

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Endothelial growth factor. Timepoint: Basal state and after 8 week. Method of measurement: Based on nanogram per liter with ELISA method.;Nitric oxaide. Timepoint: Basal state and after 8 week. Method of measurement: Based on micromole per liter with ELISA method.;Interleukin- 8. Timepoint: Basal state and after 8 week. Method of measurement: Based on nanogram per liter with ELISA method.;Interleukin- 4. Timepoint: Based on nanogram per liter with ELISA method. Method of measurement: Basal state and after 8 week.;Blood pressure. Timepoint: Basal state and after 8 week. Method of measurement: Based on millimeters of mercury using a digital arm manometer.	—

Measure

Time frame

Endothelial growth factor. Timepoint: Basal state and after 8 week. Method of measurement: Based on nanogram per liter with ELISA method.;Nitric oxaide. Timepoint: Basal state and after 8 week. Method of measurement: Based on micromole per liter with ELISA method.;Interleukin- 8. Timepoint: Basal state and after 8 week. Method of measurement: Based on nanogram per liter with ELISA method.;Interleukin- 4. Timepoint: Based on nanogram per liter with ELISA method. Method of measurement: Basal state and after 8 week.;Blood pressure. Timepoint: Basal state and after 8 week. Method of measurement: Based on millimeters of mercury using a digital arm manometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Hakimi

Mohaghegh Ardabili University

Mehdihakimi@uma.ac.ir+98 45 3150 5625

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026